Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Decision Making in Oncology.

Putora PM.

JCO Clin Cancer Inform. 2019 Feb;3:1-2. doi: 10.1200/CCI.18.00116. No abstract available.

2.

Treatment Options in Oncology.

Panje CM, Glatzer M, Sirén C, Plasswilm L, Putora PM.

JCO Clin Cancer Inform. 2018 Dec;2:1-10. doi: 10.1200/CCI.18.00017.

3.

Electronic Patient-Reported Outcomes: A New Standard of Care?

Putora PM.

Oncology. 2018 Dec 12:1-2. doi: 10.1159/000494925. [Epub ahead of print] No abstract available.

4.

Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries.

Rich A, Baldwin D, Alfageme I, Beckett P, Berghmans T, Brincat S, Burghuber O, Corlateanu A, Cufer T, Damhuis R, Danila E, Domagala-Kulawik J, Elia S, Gaga M, Goksel T, Grigoriu B, Hillerdal G, Huber RM, Jakobsen E, Jonsson S, Jovanovic D, Kavcova E, Konsoulova A, Laisaar T, Makitaro R, Mehic B, Milroy R, Moldvay J, Morgan R, Nanushi M, Paesmans M, Putora PM, Samarzija M, Scherpereel A, Schlesser M, Sculier JP, Skrickova J, Sotto-Mayor R, Strand TE, Van Schil P, Blum TG.

BMC Cancer. 2018 Nov 20;18(1):1144. doi: 10.1186/s12885-018-5009-y.

5.

ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe.

Rich AL, Baldwin DR, Beckett P, Berghmans T, Boyd J, Faivre-Finn C, Galateau-Salle F, Gamarra F, Grigoriu B, Hansen NG, Hardavella G, Jakobsen E, Jovanovic D, Konsoulova A, Massard G, McPhelim J, Meert AP, Milroy R, Mutti L, Paesmans M, Peake MD, Putora PM, de Ruysscher DKM, Sculier JP, Schepereel A, Subotic DR, Van Schil P, Blum TG.

Eur Respir J. 2018 Dec 20;52(6). pii: 1800610. doi: 10.1183/13993003.00610-2018. Print 2018 Dec.

PMID:
30361252
6.

Multidisciplinary treatment of lung cancer in older patients: A review.

Radovic M, Kanesvaran R, Rittmeyer A, Früh M, Minervini F, Glatzer M, Putora PM.

J Geriatr Oncol. 2018 Oct 3. pii: S1879-4068(18)30198-X. doi: 10.1016/j.jgo.2018.09.005. [Epub ahead of print] Review.

PMID:
30292418
7.

Current efforts in research of pleural mesothelioma-An analysis of the ClinicalTrials.gov registry.

Süveg K, Putora PM, Berghmans T, Glatzer M, Kovac V, Cihoric N.

Lung Cancer. 2018 Oct;124:12-18. doi: 10.1016/j.lungcan.2018.07.007. Epub 2018 Jul 5.

PMID:
30268449
8.

Introduction to the New Section "Oncology and Informatics".

Putora PM, Markman M.

Oncology. 2018 Sep 25:1. doi: 10.1159/000490896. [Epub ahead of print] No abstract available.

9.

Decision Making Criteria in Oncology.

Glatzer M, Panje CM, Sirén C, Cihoric N, Putora PM.

Oncology. 2018 Sep 18:1-9. doi: 10.1159/000492272. [Epub ahead of print] Review.

10.

The role of radiation therapy in the management of small cell lung cancer.

Glatzer M, Schmid S, Radovic M, Früh M, Putora PM.

Breathe (Sheff). 2017 Dec;13(4):e87-e94. doi: 10.1183/20734735.009617. Review.

11.

Surgical management of urolithiasis - a systematic analysis of available guidelines.

Zumstein V, Betschart P, Abt D, Schmid HP, Panje CM, Putora PM.

BMC Urol. 2018 Apr 10;18(1):25. doi: 10.1186/s12894-018-0332-9.

12.

ESTRO ACROP guidelines for target volume definition in the treatment of locally advanced non-small cell lung cancer.

Nestle U, De Ruysscher D, Ricardi U, Geets X, Belderbos J, Pöttgen C, Dziadiuszko R, Peeters S, Lievens Y, Hurkmans C, Slotman B, Ramella S, Faivre-Finn C, McDonald F, Manapov F, Putora PM, LePéchoux C, Van Houtte P.

Radiother Oncol. 2018 Apr;127(1):1-5. doi: 10.1016/j.radonc.2018.02.023. Epub 2018 Mar 28.

PMID:
29605476
13.

Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert Survey.

Rothermundt C, Fischer GF, Bauer S, Blay JY, Grünwald V, Italiano A, Kasper B, Kollár A, Lindner LH, Miah A, Sleijfer S, Stacchiotti S, Putora PM.

Oncologist. 2018 Apr;23(4):461-467. doi: 10.1634/theoncologist.2017-0391. Epub 2017 Nov 30. Review.

PMID:
29192019
14.

Impact of dose intensified salvage radiation therapy on urinary continence recovery after radical prostatectomy: Results of the randomized trial SAKK 09/10.

Ghadjar P, Hayoz S, Bernhard J, Zwahlen DR, Stein J, Hölscher T, Gut P, Polat B, Hildebrandt G, Müller AC, Putora PM, Papachristofilou A, Schär C, Dal Pra A, Biaggi Rudolf C, Wust P, Aebersold DM, Thalmann GN; Swiss Group for Clinical Cancer Research (SAKK).

Radiother Oncol. 2018 Feb;126(2):257-262. doi: 10.1016/j.radonc.2017.10.025. Epub 2017 Nov 3.

PMID:
29103826
15.

Treatment of limited disease small cell lung cancer: the multidisciplinary team.

Glatzer M, Rittmeyer A, Müller J, Opitz I, Papachristofilou A, Psallidas I, Früh M, Born D, Putora PM.

Eur Respir J. 2017 Aug 24;50(2). pii: 1700422. doi: 10.1183/13993003.00422-2017. Print 2017 Aug. Review.

16.

Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis.

Panje CM, Glatzer M, von Rappard J, Rothermundt C, Hundsberger T, Zumstein V, Plasswilm L, Putora PM.

BMC Med Res Methodol. 2017 Aug 16;17(1):123. doi: 10.1186/s12874-017-0400-y.

17.

Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : A national survey on patterns of practice.

Dal Pra A, Panje C, Zilli T, Arnold W, Brouwer K, Garcia H, Glatzer M, Gomez S, Herrera F, Kaouthar K, Papachristofilou A, Pesce G, Reuter C, Vees H, Zwahlen DR, Engeler D, Putora PM.

Strahlenther Onkol. 2018 Jan;194(1):9-16. doi: 10.1007/s00066-017-1172-3. Epub 2017 Jun 27.

PMID:
28656373
18.

Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis.

Warschkow R, Güller U, Cerny T, Schmied BM, Plasswilm L, Putora PM.

Radiother Oncol. 2017 Apr;123(1):139-146. doi: 10.1016/j.radonc.2017.02.007. Epub 2017 Mar 9.

PMID:
28285840
19.

Thoracic oncology HERMES: European curriculum recommendations for training in thoracic oncology.

Gamarra F, Noël JL, Brunelli A, Dingemans AC, Felip E, Gaga M, Grigoriu BD, Hardavella G, Huber RM, Janes S, Massard G, Putora PM, Sculier JP, Schnabel PA, Ramella S, Van Raemdonck D, Meert AP.

Breathe (Sheff). 2016 Sep;12(3):249-255. doi: 10.1183/20734735.009116. Review.

20.

Importance and outcome relevance of central pathology review in prostatectomy specimens: data from the SAKK 09/10 randomized trial on prostate cancer.

Ghadjar P, Hayoz S, Genitsch V, Zwahlen DR, Hölscher T, Gut P, Guckenberger M, Hildebrandt G, Müller AC, Putora PM, Papachristofilou A, Stalder L, Biaggi-Rudolf C, Sumila M, Kranzbühler H, Najafi Y, Ost P, Azinwi NC, Reuter C, Bodis S, Khanfir K, Budach V, Aebersold DM, Thalmann GN; Swiss Group for Clinical Cancer Research (SAKK).

BJU Int. 2017 Nov;120(5B):E45-E51. doi: 10.1111/bju.13742. Epub 2017 Jan 19.

21.

SUVmax and Tumour Location in PET-CT Predict Oncogene Status in Lung Cancer.

Putora PM, Szentesi K, Glatzer M, Rodriguez R, Müller J, Baty F, Früh M.

Oncol Res Treat. 2016;39(11):681-686. Epub 2016 Oct 19.

PMID:
27855379
22.

Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithms.

Rothermundt C, von Rappard J, Eisen T, Escudier B, Grünwald V, Larkin J, McDermott D, Oldenburg J, Porta C, Rini B, Schmidinger M, Sternberg CN, Putora PM.

World J Urol. 2017 Apr;35(4):641-648. doi: 10.1007/s00345-016-1903-6. Epub 2016 Aug 3.

PMID:
27488984
23.

Handheld single photon emission computed tomography (handheld SPECT) navigated video-assisted thoracoscopic surgery of computer tomography-guided radioactively marked pulmonary lesions.

Müller J, Putora PM, Schneider T, Zeisel C, Brutsche M, Baty F, Markus A, Kick J.

Interact Cardiovasc Thorac Surg. 2016 Sep;23(3):345-50. doi: 10.1093/icvts/ivw136. Epub 2016 May 20.

PMID:
27207315
24.

[Meningioma: management of the most common brain tumour].

Hundsberger T, Surbeck W, Hader C, Putora PM, Conen K, Roelcke U.

Praxis (Bern 1994). 2016 Apr 13;105(8):445-51. doi: 10.1024/1661-8157/a002320. Review. German.

PMID:
27078728
25.

Radio(chemo)therapy in locally advanced nonsmall cell lung cancer.

Glatzer M, Elicin O, Ramella S, Nestle U, Putora PM.

Eur Respir Rev. 2016 Mar;25(139):65-70. doi: 10.1183/16000617.0053-2015. Review.

26.

Endoscopic dilation of complete oesophageal obstructions with a combined antegrade-retrograde rendezvous technique.

Bertolini R, Meyenberger C, Putora PM, Albrecht F, Broglie MA, Stoeckli SJ, Sulz MC.

World J Gastroenterol. 2016 Feb 21;22(7):2366-72. doi: 10.3748/wjg.v22.i7.2366.

27.

Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients.

Putora PM, Engeler D, Haile SR, Graf N, Buchauer K, Schmid HP, Plasswilm L.

Strahlenther Onkol. 2016 Mar;192(3):182-9. doi: 10.1007/s00066-015-0928-x. Epub 2015 Dec 28.

PMID:
26713323
28.

Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes.

Hundsberger T, Hottinger AF, Roelcke U, Roth P, Migliorini D, Dietrich PY, Conen K, Pesce G, Hermann E, Pica A, Gross MW, Brügge D, Plasswilm L, Weller M, Putora PM.

J Neurooncol. 2016 Jan;126(1):175-183. doi: 10.1007/s11060-015-1957-0. Epub 2015 Oct 12.

29.

Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma--Analysis Using Diagnostic Nodes.

Rothermundt C, Bailey A, Cerbone L, Eisen T, Escudier B, Gillessen S, Grünwald V, Larkin J, McDermott D, Oldenburg J, Porta C, Rini B, Schmidinger M, Sternberg C, Putora PM.

Oncologist. 2015 Sep;20(9):1028-35. doi: 10.1634/theoncologist.2015-0145. Epub 2015 Aug 3.

30.

PSA bounce after ¹²⁵I-brachytherapy for prostate cancer as a favorable prognosticator.

Engeler DS, Schwab C, Thöni AF, Hochreiter W, Prikler L, Suter S, Stucki P, Schiefer J, Plasswilm L, Schmid HP, Putora PM.

Strahlenther Onkol. 2015 Oct;191(10):787-91. doi: 10.1007/s00066-015-0860-0. Epub 2015 Jun 23.

PMID:
26100965
31.

Oesophageal cancer: exploring controversies overview of experts' opinions of Austria, Germany, France, Netherlands and Switzerland.

Putora PM, Bedenne L, Budach W, Eisterer W, Van Der Gaast A, Jäger R, Van Lanschot JJ, Mariette C, Schnider A, Stahl M, Ruhstaller T.

Radiat Oncol. 2015 May 21;10:116. doi: 10.1186/s13014-015-0418-4.

32.

Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.

Panje CM, Dal Pra A, Zilli T, R Zwahlen D, Papachristofilou A, Herrera FG, Matzinger O, Plasswilm L, Putora PM.

Strahlenther Onkol. 2015 Oct;191(10):778-86. doi: 10.1007/s00066-015-0849-8. Epub 2015 May 19.

PMID:
25986251
33.

Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience.

Panje C, Panje T, Putora PM, Kim SK, Haile S, Aebersold DM, Plasswilm L.

Radiat Oncol. 2015 Feb 22;10:47. doi: 10.1186/s13014-015-0338-3.

34.

Prognostic significance of histology after resection of brain metastases and whole brain radiotherapy in non-small cell lung cancer (NSCLC).

Putora PM, Ess S, Panje C, Hundsberger T, van Leyen K, Plasswilm L, Früh M.

Clin Exp Metastasis. 2015 Feb;32(2):143-9. doi: 10.1007/s10585-015-9699-0. Epub 2015 Jan 28.

PMID:
25628027
35.

Objective consensus from decision trees.

Putora PM, Panje CM, Papachristofilou A, Dal Pra A, Hundsberger T, Plasswilm L.

Radiat Oncol. 2014 Dec 5;9:270. doi: 10.1186/s13014-014-0270-y.

36.

Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients.

Hundsberger T, Tonder M, Hottinger A, Brügge D, Roelcke U, Putora PM, Stupp R, Weller M.

J Neurooncol. 2014 Jun;118(2):321-328. doi: 10.1007/s11060-014-1434-1. Epub 2014 Apr 16.

37.

The European initiative for quality management in lung cancer care.

Blum TG, Rich A, Baldwin D, Beckett P, De Ruysscher D, Faivre-Finn C, Gaga M, Gamarra F, Grigoriu B, Hansen NC, Hubbard R, Huber RM, Jakobsen E, Jovanovic D, Konsoulova A, Kollmeier J, Massard G, McPhelim J, Meert AP, Milroy R, Paesmans M, Peake M, Putora PM, Scherpereel A, Schönfeld N, Sitter H, Skaug K, Spiro S, Strand TE, Taright S, Thomas M, van Schil PE, Vansteenkiste JF, Wiewrodt R, Sculier JP.

Eur Respir J. 2014 May;43(5):1254-77. doi: 10.1183/09031936.00106913. Epub 2014 Mar 23.

38.

The Kafkaesque process of cancer diagnosis.

Putora PM, Oldenburg J.

J Clin Oncol. 2014 Apr 1;32(10):1087-8. doi: 10.1200/JCO.2013.54.2449. Epub 2014 Mar 3. No abstract available.

PMID:
24590639
39.

Swarm-based medicine.

Putora PM, Oldenburg J.

J Med Internet Res. 2013 Sep 19;15(9):e207. doi: 10.2196/jmir.2452.

40.

Re-implantation after insufficient primary 125-i permanent prostate brachytherapy.

Putora PM, Plasswilm L, Seelentag W, Schiefer J, Markart P, Schmid HP, Engeler D.

Radiat Oncol. 2013 Aug 6;8:194. doi: 10.1186/1748-717X-8-194.

41.

Comorbidities and burden of COPD: a population based case-control study.

Baty F, Putora PM, Isenring B, Blum T, Brutsche M.

PLoS One. 2013 May 17;8(5):e63285. doi: 10.1371/journal.pone.0063285. Print 2013.

42.

Relevance of incidental colorectal FDG-PET/CT-enhanced lesions.

Putora PM, Müller J, Borovicka J, Plasswilm L, Schmidt F.

Onkologie. 2013;36(4):200-4. doi: 10.1159/000350302. Epub 2013 Mar 18.

PMID:
23548969
43.

FDG-PET SUV-max values do not correlate with epidermal growth factor receptor mutation status in lung adenocarcinoma.

Putora PM, Früh M, Müller J.

Respirology. 2013 May;18(4):734-5. doi: 10.1111/resp.12083.

PMID:
23489365
44.

Re-irradiation with and without bevacizumab as salvage therapy for recurrent or progressive high-grade gliomas.

Hundsberger T, Brügge D, Putora PM, Weder P, Weber J, Plasswilm L.

J Neurooncol. 2013 Mar;112(1):133-9. doi: 10.1007/s11060-013-1044-3. Epub 2013 Jan 12.

PMID:
23314822
45.

Compensability index for compensation radiotherapy after treatment interruptions.

Putora PM, Schmuecking M, Aebersold D, Plasswilm L.

Radiat Oncol. 2012 Dec 8;7:208. doi: 10.1186/1748-717X-7-208.

46.

[Castration-resistant prostate cancer: surgical and radio-oncological therapeutic options].

Preusser S, Putora PM, Plasswilm L, Schmid HP.

Urologe A. 2012 Jan;51(1):27-31. doi: 10.1007/s00120-011-2742-0. German.

PMID:
22258373
47.

Tracheal granuloma pyogenicum with erlotinib treatment for lung cancer.

Putora PM, Benz G, Rodriguez R, Brutsche M, Früh M.

Eur Respir J. 2011 Nov;38(5):1228-30. doi: 10.1183/09031936.00008411. No abstract available.

48.

Have you ever heard of hibernoma? A rare but important pitfall in FDG-PET/CT.

Schmidt F, Cathomas R, Stallmach T, Putora PM, Mueller J.

Nuklearmedizin. 2010;49(6):N71-3. No abstract available.

PMID:
21140031
49.

Smoking habits of medical students in Bratislava, Slovak Republic.

Urban S, Putora PM.

Bratisl Lek Listy. 2009;110(9):582. No abstract available.

PMID:
19827345

Supplemental Content

Loading ...
Support Center